with the top 10 largest pharmaceutical companies of the world
in the last 3 years
co-working to resolve complex issues
Pepeliaev Group’s lawyers provided support to one of the world’s largest pharmaceutical companies performing clinical trials in Russia
DetailPepeliaev Group’s services also encompass legal support for Russian and global companies in relation to the legal aspects of business development, namely, investing in production and acquisition of new assets
DetailFor several years, Pepeliaev Group’s experts have successfully supported the activities of two biotech startups created by foreign investors together with one of the Russian development institutes.
DetailPepeliaev Group’s lawyers have advised one of the 10 world’s largest pharmaceutical companies on a broad spectrum of issues concerning its current activities
DetailPepeliaev Group’s lawyers have advised a major international manufacturer of homoeopathic medicines on issues relating to a change in the distribution model in Russia
DetailThe experts of our antitrust practice have conducted a lot of antitrust audits in relation to the activities of pharmaceutical companies, accumulating thus a wealth of knowledge concerning the specifics of this industry’s business in the Russian market.
DetailPepeliaev Group’s lawyers have provided legal support to a client within the framework of organising the contractual manufacturing of active pharmaceutical ingredients and biological substances jointly with a Russian pharmaceutical company.
DetailPepeliaev Group’s lawyers have developed several options of formalising contractual relationships with sales outlets aimed at marketing the company’s products if there are no supplier-recipient relationships for such products.
DetailPepeliaev Group’s experts have consulted a client in relation to the tax implications and risks pertaining to a contract for the manufacturing and selling a medicine within a group of affiliated companies, taking into account the actual distribution of functions and pharmaceutical licences.
DetailPepeliaev Group’s lawyers have handled the closure of a representative office which pursued auxiliary and preparatory activities in Russia, and successfully protected the company's interests at the stage of the pre-audit analysis by the tax authority.
DetailPepeliaev Group’s lawyers have devised a contractual model for foreign software to be sold in Russia (including for payments to be accepted for updates and additional features of the software), taking into account the tax risks.
DetailPepeliaev Group’s lawyers have provided advice on tax and regulatory issues concerning a manufacturer of medical products interacting with healthcare professionals.
DetailThe lawyers of Pepeliaev Group’s tax department have devised documents minimising tax risks when paying expenses on healthcare professionals.
DetailPepeliaev Group’s lawyers have summarised court practice relating to the tax classification of contracts for the organisation of the study of medicines, developed arguments in case the tax authority would raise claims and supported the client in gathering evidence (prepared the defence files) ensuring the defence of the client's interests during a tax audit.
DetailPepeliaev Group’s lawyers have represented a pharmaceutical company in a dispute with the tax authority in relation to VAT being collected on the cost of the work aimed at organising clinical studies. We won the dispute in the first instance court.
DetailThe lawyers of Pepeliaev Group's tax department have supported transactions aimed at exporting medicines into foreign markets.
DetailLawyers of the practice provided legal support during a project that involved the restructuring of the business of a European pharmaceutical company (group of companies) in Russia.
DetailFor a Chinese pharmaceutical company, lawyers of the practice conducted an audit of regulatory risks associated with products that were imported into Russia.
DetailLawyers of the Life Sciences Practice represented a major international pharmaceutical company which devised a methodology for measuring certain substances in waste water.
DetailIlya specialises in corporate and contract law. For over 20 years, he has advised Russian and non-Russian clients on investments in Russia, M&A transactions, commercial and contract law and on antimonopoly regulation (including asset acquisitions, restructurings, the formation of joint ventures, and the integrated structuring of contractual relationships in Russia), including when working with Life Science companies. A significant part of Ilya’s practice is dedicated to work with Life Science and FMCG companies
Ilya specialises in corporate and contract law. For over 20 years, he has advised Russian and non-Russian clients on investments in Russia, M&A transactions, commercial and contract law and on antimonopoly regulation (including asset acquisitions, restructurings, the formation of joint ventures, and the integrated structuring of contractual relationships in Russia), including when working with Life Science companies. A significant part of Ilya’s practice is dedicated to work with Life Science and FMCG companies
Maria specialises in taxation in the pharmaceutical industry and FMCG. She advises on tax risks in sales of medicines, the conduct of clinical trials, the promotion of medicines and food supplements, as well as on other issues of pharmaceutical companies’ business. She has a track record of providing legal support to large international and Russian companies when analysing and structuring their operations with a view to maximising their efficiency and minimising risk exposure. Maria has frequently litigated on behalf of various companies on tax issues in courts of all levels and before other state bodies.
Maria specialises in taxation in the pharmaceutical industry and FMCG. She advises on tax risks in sales of medicines, the conduct of clinical trials, the promotion of medicines and food supplements, as well as on other issues of pharmaceutical companies’ business. She has a track record of providing legal support to large international and Russian companies when analysing and structuring their operations with a view to maximising their efficiency and minimising risk exposure. Maria has frequently litigated on behalf of various companies on tax issues in courts of all levels and before other state bodies.
By continuing to view this website, you agree with cookie files and other Internet statistics and configuration methods, means and tools being used that are applied on the website to make it more user friendly as well as, in certain cases, to promote the work and services of Pepeliaev Group and to provide information about upcoming events.